Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II–III NSCLC
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S221
DOI: 10.1016/j.ijrobp.2026.06.470 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von J. van Diessen und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Diessen, J. V., Niazi, L., Hassan, S., Belderbos, J., Damhuis, R., & Theelen, W. (2026). Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II–III NSCLC. International Journal of Radiation Oncology*Biology*Physics, 126(1), S221. https://doi.org/10.1016/j.ijrobp.2026.06.470
Vancouver
Diessen JV, Niazi L, Hassan S, Belderbos J, Damhuis R, Theelen W. Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II–III NSCLC. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S221. doi:10.1016/j.ijrobp.2026.06.470
BibTeX
@article{Diessen2026,
author = {Diessen, J. van and Niazi, L. and Hassan, S.V. and Belderbos, J. and Damhuis, R. and Theelen, W.V.},
title = {Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II–III NSCLC},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S221},
doi = {10.1016/j.ijrobp.2026.06.470}
}
EUVIMED